fda approved oral semaglutide New Dosage Forms by Oral Semaglutide Gets FDA Approval

The company developed semaglutide as a once-weekly GLP-1 receptor agonist initially approved by the FDA in 2017 for type 2 diabetes management under the brand name Ozempic

Daniel Bessesen, chief endocrinologist at the University of Colorado School of Medicine

No harsh acids

Eli Lillys Phase 3 TRIUMPH-4 trial (December 2025) reported that participants taking 12mg of Retatrutide over 68 weeks lost an average of 28.7% of their body weight, the highest result ever reported at that stage for any obesity-related compound

This attrition is what scientists call the Hayflick limit, named after Leonard Hayflick, who discovered that normal human cells divide roughly 4060 times before stopping [23]

Other drugs in the same group as propranolol also hide these signs of low blood sugar